Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial

BACKGROUND: Mass drug administration (MDA) of azithromycin (AZI) has been shown to reduce under-5 mortality in some but not all sub-Saharan African settings. A large-scale cluster-randomized trial conducted in Malawi, Niger, and Tanzania suggested that the effect differs by country, may be stronger...

Descripción completa

Detalles Bibliográficos
Autores principales: Adubra, Laura, Alber, Dagmar, Ashorn, Per, Ashorn, Ulla, Cheung, Yin Bun, Cloutman-Green, Elaine, Diallo, Fatoumata, Ducker, Camilla, Elovainio, Riku, Fan, Yue-Mei, Gates, Lily, Gruffudd, Gwydion, Haapaniemi, Tiia, Haidara, Fadima, Hallamaa, Lotta, Ihamuotila, Rikhard, Klein, Nigel, Luoma, Juho, Martell, Owen, Sow, Samba, Vehmasto, Taru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809521/
https://www.ncbi.nlm.nih.gov/pubmed/36597115
http://dx.doi.org/10.1186/s13063-022-06966-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809521/
https://www.ncbi.nlm.nih.gov/pubmed/36597115
http://dx.doi.org/10.1186/s13063-022-06966-7

Ejemplares similares